🧠 Engineered Human Neurons Model Late-Stage #Tauopathy. This study presents a human induced pluripotent stem cell ( #iPSC )–based neuronal model that reproduces key features of late-stage tauopathies.
🔗Read a summary of the study on our website: synergy-munich.de/news-events/...
LMU Klinikum Munich is recruiting a Postdoctoral Researcher in iPSC Models of Neurovascular Diseases at the Institute for Stroke & Dementia Research. Join PaquetLab to work on CRISPR, BBB modelling and neurovascular disease. Closing date: 17th April
www.dementiaresearcher.nihr.ac.uk/job/postdoc-...
Excited to be at #Tau2025 in London! I really enjoy the great and inspiring discussions with all the fellow Tau enthusiasts! 🔬👩🔬
LMU Klinikum Munich seeks a Postdoctoral Researcher in iPSC neurovascular models at the Institute for Stroke and Dementia Research, PaquetLab.
www.dementiaresearcher.nihr.ac.uk
🎉 So excited to receive the #DeutscherStudienpreis (German Thesis Award) by the @koerber-ip.bsky.social handed over by the German Head of Parliament @bundestag.de. I got recognized for my work on novel human experimental models of dementia in the lab of @paquetlab.bsky.social.
Very proud of our new paper, which I worked on in the @paquetlab.bsky.social for the past years! 👩🔬 Out this week in Science Translational Medicine @science.org. Find all the exciting details on what we found here 👇
Huge shout out also to the other awardees across all disciplines: Christina Eisenbarth, @konigmattern.bsky.social, @heinkelmann-wild.bsky.social, Anna Kristin Biedermann, Anna Billerbeck, @larabister.bsky.social, Christian Ollig, and Joey Rauschenberg.
My research at @isd-research.bsky.social, @lmumuenchen.bsky.social, @synergy-munich.bsky.social focused on more physiological, human-based models that better reflect actual disease processes - and thus contribute to the global effort towards more effective dementia treatments tinyurl.com/3thjnvzs
